AT519109T - Preeclampsia-DIAGNOSIS - Google Patents

Preeclampsia-DIAGNOSIS

Info

Publication number
AT519109T
AT519109T AT05857213T AT05857213T AT519109T AT 519109 T AT519109 T AT 519109T AT 05857213 T AT05857213 T AT 05857213T AT 05857213 T AT05857213 T AT 05857213T AT 519109 T AT519109 T AT 519109T
Authority
AT
Austria
Prior art keywords
preeclampsia
diagnosis
Prior art date
Application number
AT05857213T
Other languages
German (de)
Inventor
Irina Buhimschi
Catalin Buhimschi
Errol Norwitz
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US63794804P priority Critical
Application filed by Univ Yale filed Critical Univ Yale
Priority to PCT/US2005/047010 priority patent/WO2006069373A2/en
Publication of AT519109T publication Critical patent/AT519109T/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/321Arterial hypertension
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
AT05857213T 2004-12-21 2005-12-21 Preeclampsia-DIAGNOSIS AT519109T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US63794804P true 2004-12-21 2004-12-21
PCT/US2005/047010 WO2006069373A2 (en) 2004-12-21 2005-12-21 Diagnosis of preeclampsia

Publications (1)

Publication Number Publication Date
AT519109T true AT519109T (en) 2011-08-15

Family

ID=36602368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05857213T AT519109T (en) 2004-12-21 2005-12-21 Preeclampsia-DIAGNOSIS

Country Status (7)

Country Link
US (3) US7727733B2 (en)
EP (2) EP2434283B1 (en)
JP (1) JP5009811B2 (en)
CN (1) CN101163970A (en)
AT (1) AT519109T (en)
ES (2) ES2475975T3 (en)
WO (1) WO2006069373A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
ES2534926T3 (en) * 2002-07-19 2015-04-30 Beth Israel Deaconess Medical Center Methods to treat preeclampsia
US7335362B2 (en) 2002-07-19 2008-02-26 Beth Israel Deaconess Medical Center Methods of treating pre-eclampsia or eclampsia
AU2005244167A1 (en) * 2004-05-04 2005-11-24 Beth Israel Deaconess Medical Center Methods and compositions for treatment of preeclampsia
US7740849B2 (en) * 2004-09-24 2010-06-22 Beth Israel Deaconess Medical Center Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
MX2007003522A (en) * 2004-09-24 2007-06-11 Beth Israel Hospital Methods of diagnosing and treating complications of pregnancy.
US20090286271A1 (en) * 2006-05-31 2009-11-19 Karumanchi Ananth S Methods of Diagnosing and Treating Complications of Pregnancy
DE602005023216D1 (en) 2004-12-15 2010-10-07 Beth Israel Hospital Nucleic acids and polypeptides for the diagnosis and treatment of pregnancy complications
JP5009811B2 (en) * 2004-12-21 2012-08-22 イェール ユニバーシティ Detection of preeclampsia
CA2602963A1 (en) * 2005-03-24 2006-09-28 Beth Israel Deaconess Medical Center Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
WO2007051069A2 (en) * 2005-10-27 2007-05-03 Yale University Urinary proteomic biomarker patterns in preeclampsia
US20070111326A1 (en) * 2005-11-14 2007-05-17 Abbott Laboratories Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
ES2350255T3 (en) * 2006-09-20 2011-01-20 F. Hoffmann-La Roche Ag Natural peptides and the vegf placentary growth / receiver growth factor discriminate the heart dysfunction related to a heart disease associated with a heart dysfunction associated in the woman.
WO2008075363A1 (en) * 2006-12-20 2008-06-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions
CN101259119B (en) * 2007-03-08 2010-05-19 上海市计划生育科学研究所 Application of serine protease inhibitor and its derivative in fertility regulation
CN101918834B (en) 2008-01-07 2014-05-28 奥索临床诊断有限公司 Calibrator/control for simultaneous assay of proteins capable of complexing with one another
US8835183B2 (en) 2008-01-07 2014-09-16 Ortho-Clinical Diagnostics, Inc. Determination of sFlt-1:angiogenic factor complex
EP3109322A1 (en) * 2008-01-25 2016-12-28 Wallac Oy Methods for determining the risk of prenatal complications
WO2009108073A1 (en) * 2008-02-28 2009-09-03 Auckland Uniservices Limited Biomarkers for prediction of preeclampsia and/or cardiovascular disease
CN107677828A (en) 2008-10-31 2018-02-09 耶鲁大学 Preeclampsia detects and the method and composition for the treatment of
US8574851B2 (en) * 2008-11-24 2013-11-05 Corthera, Inc. Prediction and prevention of preeclampsia
US20120101021A1 (en) 2009-02-06 2012-04-26 Surendra Sharma Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
CN101643785B (en) * 2009-06-18 2011-12-21 中国人民解放军第二军医大学 hsa-mir-210 kit for detecting pregnancy-hypertension syndrome and detecting method thereof
US20110251094A1 (en) 2010-04-13 2011-10-13 Pronota N.V. Biomarkers for hypertensive disorders of pregnancy
WO2011128357A2 (en) * 2010-04-13 2011-10-20 Pronota N.V. Biomarkers for hypertensive disorders of pregnancy
EP3248946A1 (en) * 2010-05-14 2017-11-29 Beth Israel Deaconess Medical Center Extracorporeal devices and methods of treating complications of pregnancy
EP2766726A1 (en) 2011-10-14 2014-08-20 Aarhus Universitet Diagnostic and prognostic use of prombp-complexes
US20150087553A1 (en) * 2012-04-13 2015-03-26 Bioscreening and Diagnostics, LLC Early trimester screening for early- and late-onset preeclampsia
GB2515983A (en) * 2012-05-08 2015-01-07 Univ Leland Stanford Junior Methods and compositions for providing a preeclampsia assessment
CA2871878A1 (en) 2012-06-27 2014-01-03 F. Hoffmann-La Roche Ag Means and methods applying sflt-1/pigf or endoglin/pigf ratio to rule-out onset of preeclampsia within a certain time period
SG11201501065QA (en) * 2012-09-04 2015-03-30 Pluristem Ltd Methods for prevention and treatment of preeclampsia
RU2519083C1 (en) * 2012-10-29 2014-06-10 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ ОММ" Минздравсоцразвития России) Method for prediction of hypertension complications of pregnancy in patients suffering from gestational diabetes mellitus
GB201303649D0 (en) 2013-03-01 2013-04-17 Univ Aston Hydrogen sulphide compounds
CN103207274B (en) * 2013-04-28 2015-02-25 成都中医药大学 Screening kit for seventh chromosome abnormality diseases of fetus
FR3017955B1 (en) * 2014-02-27 2018-04-06 Assistance Publique - Hopitaux De Paris Biomarkers diagnostics of peripartum cardiomyopathy
CA2945058A1 (en) 2014-04-10 2015-10-15 Yale University Methods and compositions for detecting misfolded proteins
CA2956646A1 (en) * 2014-07-30 2016-02-04 Matthew Cooper Methods and compositions for diagnosing, prognosing, and confirming preeclampsia
EP3259600A1 (en) 2015-02-18 2017-12-27 Aston University Diagnostic assay and treatment for preeclampsia
CN108700591A (en) * 2015-09-11 2018-10-23 洛斯安第斯大学 In-vitro method for identifying pregnancy related disorder
CN107884570A (en) * 2016-09-29 2018-04-06 韦彦余 A kind of pregnant woman's pre-eclampsia detection kit

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US5998216A (en) * 1996-10-01 1999-12-07 Beth Israel Deaconess Medical Center Stabilizing formulation for preserving the integrity of proteins present in a body fluid sampled ex-vivo for evaluation as a specimen
AU5331298A (en) 1996-12-23 1998-07-17 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
CA2430889A1 (en) * 2002-06-19 2003-12-19 Bayer Corporation Stabilization of brain natriuretic peptide (bnp) in blood samples, methods and compositions related thereto
US6891006B2 (en) 2002-06-21 2005-05-10 Exxonmobil Chemical Patents Inc. Yttrium-based ethylene polymerization catalysts with bulky amidinate ancillary ligands
ES2534926T3 (en) * 2002-07-19 2015-04-30 Beth Israel Deaconess Medical Center Methods to treat preeclampsia
EP1388734B1 (en) * 2002-08-01 2004-03-03 MTM Laboratories AG Method for solution based diagnosis
ES2305541T3 (en) * 2002-11-16 2008-11-01 Dade Behring Marburg Gmbh Scd40l, papp-a and placentary growth factor (pigf) as combinations of biochemical markers in cardiovascular diseases.
DE602005023216D1 (en) * 2004-12-15 2010-10-07 Beth Israel Hospital Nucleic acids and polypeptides for the diagnosis and treatment of pregnancy complications
JP5009811B2 (en) * 2004-12-21 2012-08-22 イェール ユニバーシティ Detection of preeclampsia
WO2007051069A2 (en) 2005-10-27 2007-05-03 Yale University Urinary proteomic biomarker patterns in preeclampsia

Also Published As

Publication number Publication date
US7727733B2 (en) 2010-06-01
EP2434283B1 (en) 2014-03-26
CN101163970A (en) 2008-04-16
WO2006069373A2 (en) 2006-06-29
ES2475975T3 (en) 2014-07-11
ES2371084T3 (en) 2011-12-27
JP2008524635A (en) 2008-07-10
EP2434283A2 (en) 2012-03-28
EP1839056A2 (en) 2007-10-03
EP2434283A3 (en) 2012-07-11
WO2006069373A3 (en) 2006-11-23
EP1839056B1 (en) 2011-08-03
US8871448B2 (en) 2014-10-28
US20060183175A1 (en) 2006-08-17
US7935496B2 (en) 2011-05-03
JP5009811B2 (en) 2012-08-22
WO2006069373A8 (en) 2006-09-14
US20120040371A1 (en) 2012-02-16
EP1839056A4 (en) 2008-05-21
US20100227342A1 (en) 2010-09-09

Similar Documents

Publication Publication Date Title
LU92768I2 (en) secukinumab
DK1833840T3 (en) Micromirs
DK2332411T3 (en) Fungicidsammensætninger
DK1587343T3 (en) Höreapparat
DK1744635T3 (en) Stöbeform
DK1723700T3 (en) Højtryksstrømkabelkonnektor
DK1720859T3 (en) Chemokinreceptorantagonister
DK1737596T3 (en) Skæreværktöj
DK1746999T3 (en) 4-phenylamino-quinazolin-6-yl-amides
AT415112T (en) Abschminkapplikator
DE602005014923D1 (en) Teilchenbestrahlungssystem
DE602005017653D1 (en) Enyzmgranulat
AT415976T (en) Brombeerextrakt
DE602005015457D1 (en) ungselements
DE502005009257D1 (en) Wischblatt
AT401806T (en) Einlegesohle
AT381906T (en) Trokar
AT524255T (en) Feinguss
AT539708T (en) Wirbelfazettengelenkprothese
AT462363T (en) Polyaxialpedikelschraubenanordung
DE602004014644D1 (en) teantrieb
DE502005005116D1 (en) Wischblatt
AT457708T (en) Stentreduziersystem
DE602005013789D1 (en) -eingabeabtastung
AT538176T (en) Polymilchsäureharzzusammensetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties